PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
Gopal, Ajay K, Kahl, Brad S, de Vos, Sven, Wagner-Johnston, Nina D, Schuster, Stephen J, Jurczak, Wojciech J, Flinn, Ian W, Flowers, Christopher R, Martin, Peter, Viardot, Andreas, Blum, Kristie A, Goy, Andre H, Davies, Andrew J, Zinzani, Pier Luigi, Dreyling, Martin, Johnson, Dave, Miller, Langdon L, Holes, Leanne, Li, Daniel, Dansey, Roger D, Godfrey, Wayne R, Salles, Gilles A
Published in The New England journal of medicine (13.03.2014)
Published in The New England journal of medicine (13.03.2014)
Get full text
Journal Article
A phase 2 study of idelalisib plus rituximab in treatment-naïve older patients with chronic lymphocytic leukemia
O'Brien, Susan M., Lamanna, Nicole, Kipps, Thomas J., Flinn, Ian, Zelenetz, Andrew D., Burger, Jan A., Keating, Michael, Mitra, Siddhartha, Holes, Leanne, Yu, Albert S., Johnson, David M., Miller, Langdon L., Kim, Yeonhee, Dansey, Roger D., Dubowy, Ronald L., Coutre, Steven E.
Published in Blood (17.12.2015)
Published in Blood (17.12.2015)
Get full text
Journal Article
Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
Fizazi, Karim, Prof, Carducci, Michael, MD, Smith, Matthew, MD, Damião, Ronaldo, Prof, Brown, Janet, MD, Karsh, Lawrence, MD, Milecki, Piotr, MD, Shore, Neal, MD, Rader, Michael, MD, Wang, Huei, PhD, Jiang, Qi, PhD, Tadros, Sylvia, MPH, Dansey, Roger, MD, Goessl, Carsten, MD
Published in The Lancet (British edition) (05.03.2011)
Published in The Lancet (British edition) (05.03.2011)
Get full text
Journal Article
Denosumab and Bone Metastasis–Free Survival in Men With Nonmetastatic Castration-Resistant Prostate Cancer: Exploratory Analyses by Baseline Prostate-Specific Antigen Doubling Time
SMITH, Matthew R, SAAD, Fred, VAN VELDHUIZEN, Peter, MOROTE, Juan, ZHISHEN YE, DANSEY, Roger, GOESSL, Carsten, OUDARD, Stephane, SHORE, Neal, FIZAZI, Karim, SIEBER, Paul, TOMBAL, Bertrand, DAMIAO, Ronaldo, MARX, Gavin, MILLER, Kurt
Published in Journal of clinical oncology (20.10.2013)
Published in Journal of clinical oncology (20.10.2013)
Get full text
Journal Article
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
Stopeck, Alison T, Lipton, Allan, Body, Jean-Jacques, Steger, Guenther G, Tonkin, Katia, de Boer, Richard H, Lichinitser, Mikhail, Fujiwara, Yasuhiro, Yardley, Denise A, Viniegra, María, Fan, Michelle, Jiang, Qi, Dansey, Roger, Jun, Susie, Braun, Ada
Published in Journal of clinical oncology (10.12.2010)
Published in Journal of clinical oncology (10.12.2010)
Get full text
Journal Article
Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
HENRY, David H, COSTA, Luis, VON MOOS, Roger, WILLENBACHER, Wolfgang, WOLL, Penella J, JIANMING WANG, QI JIANG, SUSIE JUN, DANSEY, Roger, YEH, Howard, GOLDWASSER, Francois, HIRSH, Vera, HUNGRIA, Vania, PRAUSOVA, Jana, SCAGLIOTTI, Giorgio Vittorio, SLEEBOOM, Harm, SPENCER, Andrew, VADHAN-RAJ, Saroj
Published in Journal of clinical oncology (20.03.2011)
Published in Journal of clinical oncology (20.03.2011)
Get full text
Journal Article
Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial
Smith, Matthew R, Prof, Saad, Fred, Prof, Coleman, Robert, Prof, Shore, Neal, MD, Fizazi, Karim, Prof, Tombal, Bertrand, Prof, Miller, Kurt, Prof, Sieber, Paul, MD, Karsh, Lawrence, MD, Damião, Ronaldo, Prof, Tammela, Teuvo L, Prof, Egerdie, Blair, MD, Van Poppel, Hendrik, Prof, Chin, Joseph, Prof, Morote, Juan, Prof, Gómez-Veiga, Francisco, MD, Borkowski, Tomasz, Prof, Ye, Zhishen, PhD, Kupic, Amy, MA, Dansey, Roger, MD, Goessl, Carsten, MD
Published in The Lancet (British edition) (2012)
Published in The Lancet (British edition) (2012)
Get full text
Journal Article
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
FURMAN, Richard R, SHARMAN, Jeff P, GHIA, Paolo, ERADAT, Herbert, ERVIN, Thomas, LAMANNA, Nicole, COIFFIER, Bertrand, PETTITT, Andrew R, SHUO MA, STILGENBAUER, Stephan, CRAMER, Paula, AIELLO, Maria, COUTRE, Steven E, JOHNSON, Dave M, MILLER, Langdon L, LI, Daniel, JAHN, Thomas M, DANSEY, Roger D, HALLEK, Michael, O'BRIEN, Susan M, CHESON, Bruce D, PAGEL, John M, HILLMEN, Peter, BARRIENTOS, Jacqueline C, ZELENETZ, Andrew D, KIPPS, Thomas J, FLINN, Ian
Published in The New England journal of medicine (13.03.2014)
Published in The New England journal of medicine (13.03.2014)
Get full text
Journal Article
A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-to-intermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 trial
Sierra, Jorge, Szer, Jeffrey, Kassis, Jeannine, Herrmann, Richard, Lazzarino, Mario, Thomas, Xavier, Noga, Stephen J, Baker, Nigel, Dansey, Roger, Bosi, Alberto
Published in BMC cancer (10.07.2008)
Published in BMC cancer (10.07.2008)
Get full text
Journal Article
High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes
McSweeney, Peter A., Nash, Richard A., Sullivan, Keith M., Storek, Jan, Crofford, Leslie J., Dansey, Roger, Mayes, Maureen D., McDonagh, Kevin T., Nelson, J. Lee, Gooley, Theodore A., Holmberg, Leona A., Chen, C.S., Wener, Mark H., Ryan, Katherine, Sunderhaus, Julie, Russell, Ken, Rambharose, John, Storb, Rainer, Furst, Daniel E.
Published in Blood (01.09.2002)
Published in Blood (01.09.2002)
Get full text
Journal Article
New Cancer Immunotherapy Agents in Development: a report from an associated program of the 31stAnnual Meeting of the Society for Immunotherapy of Cancer, 2016
Adusumilli, Prasad S, Cha, Edward, Cornfeld, Mark, Davis, Thomas, Diab, Adi, Dubensky, Thomas W, Evans, Elizabeth, Grogan, Jane L, Irving, Bryan A, Leidner, Rom S, Olwill, Shane A, Soon-Shiong, Patrick, Triebel, Frederic, Tuck, David, Bot, Adrian, Dansey, Roger D, Drake, Charles G, Freeman, Gordon J, Ibrahim, Ramy, Patel, Salil, Chen, Daniel S
Published in Journal for Immunotherapy of Cancer (20.06.2017)
Published in Journal for Immunotherapy of Cancer (20.06.2017)
Get full text
Journal Article
Book Review
Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors
Henry, David, Vadhan-Raj, Saroj, Hirsh, Vera, von Moos, Roger, Hungria, Vania, Costa, Luis, Woll, Penella J, Scagliotti, Giorgio, Smith, Geoffrey, Feng, Amy, Jun, Susie, Dansey, Roger, Yeh, Howard
Published in Supportive care in cancer (01.03.2014)
Published in Supportive care in cancer (01.03.2014)
Get full text
Journal Article
Cost-effectiveness of denosumab vs zoledronic acid for prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States
Stopeck, Alison, Rader, Michael, Henry, David, Danese, Mark, Halperin, Marc, Cong, Ze, Qian, Yi, Dansey, Roger, Chung, Karen
Published in Journal of medical economics (01.08.2012)
Published in Journal of medical economics (01.08.2012)
Get more information
Journal Article
Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases
Nash, Richard A, Dansey, Roger, Storek, Jan, Georges, George E, Bowen, James D, Holmberg, Leona A, Kraft, George H, Mayes, Maureen D, McDonagh, Kevin T, Chen, Chien-Shing, DiPersio, John, LeMaistre, C.Fred, Pavletic, Steven, Sullivan, Keith M, Sunderhaus, Julie, Furst, Daniel E, McSweeney, Peter A
Published in Biology of blood and marrow transplantation (01.09.2003)
Published in Biology of blood and marrow transplantation (01.09.2003)
Get full text
Journal Article
PI3Kδ Inhibitor Idelalisib Inhibits AKT Signaling In Myelofibrosis Patients On Chronic JAK Inhibitor Therapy
Meadows, Sarah A, Nguyen, Huong (Marie), Queva, Christophe, Lannutti, Brian J., Kashishian, Adam, Jun, Susie, Coutre, Steven E., Dansey, Roger, Gotlib, Jason
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article
Idelalisib, a Selective Inhibitor Of PI3Kδ, In Combination With Bendamustine, Fludarabine Or Chlorambucil In Patients With Relapsed Or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)
De Vos, Sven, Furman, Richard R., Barrientos, Jacqueline C., Wagner-Johnston, Nina D., Flinn, Ian, Sharman, Jeff P., Boyd, Thomas, Leonard, John P., Dansey, Roger, Kim, Yeonhee, Holes, Leanne M., Dubowy, Ronald L., Coutre, Steven E.
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article
A Phase 1 Study Of The Selective PI3Kδ Inhibitor Idelalisib (GS-1101) In Combination With Therapeutic Anti-CD20 Antibodies (Rituximab or Ofatumumab) In Patients With Relapsed Or Refractory Chronic Lymphocytic Leukemia
Furman, Richard R., De Vos, Sven, Leonard, John P., Barrientos, Jacqueline C., Schreeder, Marshall T., Flinn, Ian W., Sharman, Jeff P., Boyd, Thomas, Fowler, Nathan, Rai, Kanti R., Kim, Yeonhee, Holes, Leanne M., Dansey, Roger, Jahn, Thomas M., Coutre, Steven E.
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article
Chemo-Immunotherapy Combination Of Idelalisib With Bendamustine/Rituximab Or Chlorambucil/Rituximab In Patients With Relapsed/Refractory CLL Demonstrates Efficacy and Tolerability
Barrientos, Jacqueline C., Wagner-Johnston, Nina D., De Vos, Sven, Coutre, Steven E., Schreeder, Marshall T., Flinn, Ian, Sharman, Jeff P., Rai, Kanti R., Leonard, John P., Dansey, Roger, Kim, Yeonhee, Holes, Leanne M., Adewoye, Henry, Furman, Richard R.
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article